[1]
“COVID-19 VACCINE LEGAL PROTECTION THROUGH PATENT FOR PUBLIC INTEREST”, TBLJ, vol. 2, no. 1, pp. 50–67, Feb. 2021, doi: 10.23920/transbuslj.v2i1.694.